These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7595713)

  • 21. Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patients.
    Jouinot A; Ulmann G; Vazeille C; Durand JP; Boudou-Rouquette P; Arrondeau J; Tlemsani C; Fournel L; Alifano M; Wislez M; Chapron J; Le Bris C; Mansuet-Lupo A; Damotte D; Neveux N; De Bandt JP; Alexandre J; Cynober L; Goldwasser F
    Clin Nutr; 2020 Jun; 39(6):1893-1899. PubMed ID: 31443979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer cachexia: measured and predicted resting energy expenditures for nutritional needs evaluation.
    Johnson G; Sallé A; Lorimier G; Laccourreye L; Enon B; Blin V; Jousset Y; Arnaud JP; Malthièry Y; Simard G; Ritz P
    Nutrition; 2008 May; 24(5):443-50. PubMed ID: 18359195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein.
    Leeuwenberg JF; Dentener MA; Buurman WA
    J Immunol; 1994 May; 152(10):5070-6. PubMed ID: 7513728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease.
    Creutzberg EC; Schols AM; Weling-Scheepers CA; Buurman WA; Wouters EF
    Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):745-52. PubMed ID: 10712317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic rate and weight loss in chronic obstructive lung disease.
    Wilson DO; Donahoe M; Rogers RM; Pennock BE
    JPEN J Parenter Enteral Nutr; 1990; 14(1):7-11. PubMed ID: 2325244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease.
    Takabatake N; Nakamura H; Abe S; Inoue S; Hino T; Saito H; Yuki H; Kato S; Tomoike H
    Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1179-84. PubMed ID: 10764309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
    Ocvirk J; Stabuc B; Rudolf Z; Galvani V; Curin-Serbec V
    Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating selectins, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in hyperthyroidism.
    Wenisch C; Myskiw D; Gessl A; Graninger W
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2122-6. PubMed ID: 7541802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accurate determination of energy needs in hospitalized patients.
    Boullata J; Williams J; Cottrell F; Hudson L; Compher C
    J Am Diet Assoc; 2007 Mar; 107(3):393-401. PubMed ID: 17324656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
    López-Lerma I; Estrach MT
    J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resting energy expenditure and body composition in patients with newly detected cancer.
    Cao DX; Wu GH; Zhang B; Quan YJ; Wei J; Jin H; Jiang Y; Yang ZA
    Clin Nutr; 2010 Feb; 29(1):72-7. PubMed ID: 19647909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective study of resting energy expenditure changes in head and neck cancer patients treated with chemoradiotherapy measured by indirect calorimetry.
    García-Peris P; Lozano MA; Velasco C; de La Cuerda C; Iriondo T; Bretón I; Camblor M; Navarro C
    Nutrition; 2005; 21(11-12):1107-12. PubMed ID: 16308133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated serum tumor necrosis factor-alpha and soluble tumor necrosis factor receptors correlate with aberrant energy metabolism in liver cirrhosis.
    Shiraki M; Terakura Y; Iwasa J; Shimizu M; Miwa Y; Murakami N; Nagaki M; Moriwaki H
    Nutrition; 2010 Mar; 26(3):269-75. PubMed ID: 19695831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resting energy expenditure in lung and colon cancer.
    Nixon DW; Kutner M; Heymsfield S; Foltz AT; Carty C; Seitz S; Casper K; Evans WK; Jeejeebhoy KN; Daly JM
    Metabolism; 1988 Nov; 37(11):1059-64. PubMed ID: 3185289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal study of resting energy expenditure, body cell mass and the inflammatory response in male patients with non-small cell lung cancer.
    Scott HR; McMillan DC; Watson WS; Milroy R; McArdle CS
    Lung Cancer; 2001 Jun; 32(3):307-12. PubMed ID: 11390012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
    Perini P; Tiberio M; Sivieri S; Facchinetti A; Biasi G; Gallo P
    Eur Cytokine Netw; 2000 Mar; 11(1):81-6. PubMed ID: 10705303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations.
    Dentener MA; Creutzberg EC; Schols AM; Mantovani A; van't Veer C; Buurman WA; Wouters EF
    Thorax; 2001 Sep; 56(9):721-6. PubMed ID: 11514694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Energy requirements in hospitalized elderly people.
    Alix E; Berrut G; Boré M; Bouthier-Quintard F; Buia JM; Chlala A; Cledat Y; d'Orsay G; Lavigne C; Levasseur R; Mouzet JB; Ombredanne MP; Sallé A; Gaillard C; Ritz P
    J Am Geriatr Soc; 2007 Jul; 55(7):1085-9. PubMed ID: 17608883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
    Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
    Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of different tumor types on resting energy expenditure.
    Fredrix EW; Soeters PB; Wouters EF; Deerenberg IM; von Meyenfeldt MF; Saris WH
    Cancer Res; 1991 Nov; 51(22):6138-41. PubMed ID: 1657379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.